Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemic Trend and Molecular Evolution of HV Family in the Main Hantavirus Epidemic Areas From 2004 to 2016, in P.R. China.

Frontiers in cellular and infection microbiology·2021
Same author

A Deep Spatial Context Guided Framework for Infant Brain Subcortical Segmentation.

Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention·2021
Same author

Grain-sized moxibustion promotes NK cell antitumour immunity by inhibiting adrenergic signalling in non-small cell lung cancer.

Journal of cellular and molecular medicine·2021
Same author

The protective effects of granulocyte-macrophage colony-stimulating factor against radiation-induced lung injury.

Translational lung cancer research·2021
Same author

Targeting Macrophages in Atherosclerosis.

Current pharmaceutical biotechnology·2021
Same author

Author Correction: Three-phase electric power driven electroluminescent devices.

Nature communications·2021

Related Experiment Video

Updated: Sep 9, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K

Incomplete Multi-Modal Disentanglement Learning With Application to Alzheimer's Disease Diagnosis.

Kangfu Han, Dan Hu, Fenqiang Zhao

    IEEE Transactions on Medical Imaging
    |August 29, 2025
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces Incomplete Multi-modal Disentanglement Learning (IMDL) for Alzheimer's disease (AD) diagnosis using incomplete neuroimaging data. IMDL effectively diagnoses AD without synthesizing missing scans, improving upon conventional methods.

    More Related Videos

    Basics of Multivariate Analysis in Neuroimaging Data
    06:35

    Basics of Multivariate Analysis in Neuroimaging Data

    Published on: July 24, 2010

    17.0K
    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
    12:18

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

    Published on: January 11, 2020

    7.6K

    Related Experiment Videos

    Last Updated: Sep 9, 2025

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    1.2K
    Basics of Multivariate Analysis in Neuroimaging Data
    06:35

    Basics of Multivariate Analysis in Neuroimaging Data

    Published on: July 24, 2010

    17.0K
    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
    12:18

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

    Published on: January 11, 2020

    7.6K

    Area of Science:

    • Neuroimaging
    • Artificial Intelligence
    • Medical Diagnostics

    Background:

    • Multi-modal neuroimaging (MRI, PET) aids Alzheimer's disease (AD) diagnosis.
    • Incomplete data is a significant challenge in current computer-aided diagnosis.
    • Existing methods for handling missing data reduce sample size or introduce noise.

    Purpose of the Study:

    • To develop a novel method for AD diagnosis using incomplete multi-modal neuroimaging data.
    • To address the limitations of conventional strategies for handling missing data in neuroimaging analysis.
    • To improve the accuracy and robustness of computer-aided diagnosis for AD.

    Main Methods:

    • Proposing Incomplete Multi-modal Disentanglement Learning (IMDL) for AD diagnosis.
    • Utilizing modality-wise variational autoencoders and a Transformer for feature fusion.
    • Implementing cross-modality contrastive learning and adversarial learning to harmonize representations.
    • Developing a local attention rectification module for enhanced localization of atrophic areas.

    Main Results:

    • IMDL demonstrated superior performance in AD diagnosis on ADNI and AIBL datasets.
    • The method effectively handles incomplete multi-modal neuroimaging data without scan synthesis.
    • Validation on the HABS-HD dataset showed effectiveness for general dementia diagnosis with different imaging modalities.

    Conclusions:

    • IMDL offers a robust and effective solution for AD diagnosis with incomplete multi-modal neuroimaging data.
    • The proposed method overcomes limitations of traditional approaches by avoiding sample reduction and noise introduction.
    • IMDL shows promise for improving diagnostic accuracy and applicability across different neuroimaging datasets and dementia types.